Table 1.
Publication Date | Diagnosis | Age | Sex | Hormonal Birth Control Use? | Vaccine | Onset of Symptoms After Vaccine |
---|---|---|---|---|---|---|
September 1, 202117 | AMN (bilateral) | 20 | Female | Vaginal hormonal contraception | Pfizer | 2 days |
September 23, 202118 | AMN (bilateral) | 23 | Female | Oral contraception | AstraZeneca | 1 day |
November 17, 202119 | AMN (bilateral) | 21 | Female | No | AstraZeneca | 3 days |
January 1, 202220 | AMN (unilateral) | 22 | Female | No | AstraZeneca | 5 days |
January 1, 202221 | AMN (bilateral) | 26 | Female | Oral contraception | Johnson & Johnson | 2 days |
January 20, 202222 | AMN (bilateral) | 25 | Female | Oral contraception | AstraZeneca | 1 day |
January 20, 202223 | AMN (bilateral) | 31 | Female | Oral contraceptive | AstraZeneca | 2 days |
January 20, 202223 | AMN (bilateral) | 19 | Female | No | AstraZeneca | 1 day |
June 22, 202124 | AMN (unilateral) | 27 | Female | Oral contraception | AstraZeneca | 2 days |
June 30, 202125 | AMN (unilateral) | 22 | Female | Oral contraception | AstraZeneca | 2 days |
June 30, 202125 | AMN (unilateral) | 28 | Female | Oral contraception | AstraZeneca | 2 days |
July 21, 202126 | AMN (bilateral) | 21 | Female | Oral contraception | AstraZeneca | 3 days |